AtaGenix is a leading contract research organization (CRO) founded in 2011, specializing in antibody and protein development services for research, diagnostics, and therapeutic R&D. Our expertise spans Single B cell, phage display, nanobody discovery, and stable cell line generation. In 2023, we launched our catalog brand, abinScience, to provide premium life science reagents that accelerate discovery. With over 14 years of proven experience and innovative solutions, AtaGenix delivers high-quality, reliable products and services to researchers worldwide.
Assay Genie
Assay Genie is dedicated to bringing smiles to scientists through exceptional support and innovative technologies. Our end-to-end workflow assay kits and antibodies accelerate biologics discovery. Explore Bioactive drug target proteins, T-cell/NK Signalling Discovery Assays, and more. From Immune Check Point to CAR-T Therapy, our comprehensive solutions empower research and development, making impactful strides in cancer studies. Join us in advancing scientific breakthroughs at Assay Genie.
Arima Genomics
Arima Genomics, Inc. is advancing human health and the life sciences by revealing actionable genomic insights. Researchers and clinicians use Arima Genomics’ innovative products and services to gain unparalleled access to the three-dimensional (3D) organization of the genome. This advanced technology enables exploration of disease mechanisms, the discovery of novel biomarkers and therapeutic targets, and identification of gene fusions to aid in patient management. To learn more, visit www.arimagenomics.com. | Arima Genomics, Inc. is advancing human genetics research by providing unparalleled insights into the three-dimensional (3D) organization of the genome. Researchers and clinicians use Arima Genomics’ innovative technologies to explore the structural and regulatory landscape of DNA, uncovering genetic mechanisms that drive health and disease. This advanced technology enables the discovery of novel biomarkers, therapeutic targets, and gene regulatory interactions, empowering breakthroughs in personalized medicine and genomic research.
Ardigen
Ardigen is your end-to-end trusted partner in the data-to-insights enablement journey that powers modern, AI-data-driven drug discovery. We help life science organizations transform fragmented, multimodal biomedical data into AI-ready foundations, actionable insights, and scalable discovery workflows. Our approach bridges the gap between data potential and discovery impact, grounded in a science-first model that starts with the biological question and aligns every step to measurable, real-world scientific outcomes. | Ardigen, a world-leading AI CRO, stands at the forefront of enabling AI transformation for the biotech and pharmaceutical sectors. Our objective is to increase the probability of success in the drug development process. We utilize our advanced platforms and deep expertise to turn vast amounts of data into pivotal, ready-to-use scientific insights. Leveraging our expertise, we also enhance the infrastructure that allows our clients to integrate and utilize these capabilities seamlessly within their organizations. | Ardigen is a leading AI Contract Research Organisation (CRO) dedicated to increasing the success rate of drug discovery. Recognized among the top 5% of AI in drug discovery companies worldwide, Ardigen integrates expertise in biology, bioinformatics, machine learning, and software engineering to deliver advanced computational solutions exclusively tailored for the biotechnology and pharmaceutical sectors. Over the past 10 years, we have earned the trust of over 120 clients, including 15 major pharmaceutical companies, by providing exceptional in silico research and data engineering services.
Applied Biological Materials Inc.
Founded in 2004, Applied Biological Materials (abm) Inc. is a pioneer in cell immortalization and expert in 3D and organoid cell culture. Based in Vancouver, Canada, our agility in developing and commercializing novel research tools and our complete portfolio of unique services have made us an invaluable partner to laboratories and research institutions around the world. Driven by a team of passionate and talented scientists, abm is dedicated to empowering the scientific community with the latest innovations for life sciences research and drug development.
ANT BIO PTE. LTD.
AntBio specializes in the research and development of recombinant antibodies and proteins, as well as various assay reagents for basic research, drug development, cell therapy, gene therapy, and in vitro diagnostics. Our product portfolio includes high-quality antibodies, target proteins, cytokines, enzymes, and assay kits, aiming to provide high-quality products and professional services to customers in the life sciences.
Almac Group
Almac Diagnostic Services We are a precision medicine company specialising in biomarker driven clinical trials. Our global CLIA and CAP accredited laboratories cover UK, Europe, USA and APAC regions. Our cores services: * Multi-Omic Services: We offer a range of genomic & proteomic platform and chemistry options, alongside expert data sciences support & a specialty central lab service. * Clinical Biomarker & CDx Development: Custom Clinical Biomarker & CDx development, validation & delivery service from our CLIA & CAP accredited laboratories in USA, Europe and APAC. * Clinical Testing: Global clinical trial testing service from our clinical laboratories, including a menu of platforms & assays and an integrated specimen collection & logistics service. Find Out More www.almacgroup.com/diagnostics | The Almac Group is an established contract development and manufacturing organization providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Operating from state-of-the-art facilities in the US, Europe, and the UK, Almac Pharma Services is a FDA, HPRA, and MHRA approved CDMO partnering with global pharmaceutical and biotechnology industries. We have over 50 years’ experience in providing a comprehensive range of tailored solutions. Almac possesses a wealth of technical expertise to support the delivery of your complex projects. Our scientists can develop your clinical candidate into an optimum formulation, and solid manufacture oral dose products for all stages of clinical trials. Almac’s integrated pharmaceutical development solutions are tailored to meet your needs. We specialise in the manufacture & primary packaging of solid, oral dosage forms (Tablets, Capsules and Powders). As well as customised secondary packaging for all drug products including ultra-low temperature drug products. Almac works in close partnership with our clients offering unique solutions designed to support the efficient and successful development, and commercialisation of new treatment options. | Operating from state-of-the-art facilities in the US, Europe, and the UK, Almac Pharma Services is a FDA, HPRA, and MHRA approved CDMO partnering with global pharmaceutical and biotechnology industries. We have over 50 years’ experience in providing a comprehensive range of tailored solutions. Providing end-to-end integrated solutions to bring your drug product from development through to commercialisation from a single source. We work with clients to provide pharmaceutical development, manufacturing, product launch, and packaging solutions to fit their unique needs. Our team of experts can support the development of fit-for-purpose formulation for First-in-Human trials, to developing a more robust formulations scaling up for late phase trials, and ultimately commercialisation. Supporting key development and manufacture areas such as paediatrics, potent and highly potent products. We provide primary and secondary packaging for all drug products including ultra-low temperature drug products and specialised kit assembly. Almac was one of the 1st EU CDMOs to support gene therapy product launches, and currently supports 25% of EU approved/pre-registration Gene Therapy solutions. We provide end-to-end management of drug product supply, including distribution, packaging design, and support initial and ongoing global product launch. We provide unique, tailormade solutions designed to support the efficient and successful development, and commercialisation of new treatment options. Partnering with our clients to provide flexible, stable, ongoing supply to meet their product pipeline needs. | The Almac Group is a global leader in providing a range of expert services and support across the drug development lifecycle. A privately owned organisation, under the McClay Foundation, Almac has grown organically over the past five decades, now employing over 7,500 highly skilled individuals across 18 locations in Europe, the US and Asia. Almac Group is comprised of 5 Business Units: • Almac Diagnostic Services • Almac Sciences • Almac Pharma Services • Almac Clinical Services • Almac Clinical Technologies Each Business Unit offers specialist and dedicated solutions at each phase of the product lifecycle providing the ability to select single or multiple, integrated solutions to meet your unique needs. Our unique combination of inspirational people, exceptional innovation and outstanding quality, enables us to provide tailored solutions for your specific requirements – either on a single, standalone project or on a long-term basis as your strategic partner. About Almac Pharma Services: With over 55 years’ experience, Almac Pharma Services is an established, reliable and world leading outsourcing partner to the global pharmaceutical and biotechnology industry. Employing over 1,800 highly skilled individuals across 4 locations in Europe and the US, we provide a range of tailored, quality-led and timely solutions from early and late phase pharmaceutical development, clinical and commercial drug product manufacture, product launch through to commercial packaging and global distribution. Currently supporting client portfolios across more than 70 countries, our fully integrated, end-to-end solutions are tailored to meet the needs of your unique products, and, ultimately, your patients. Pharmaceutical Development Solutions: Spanning both early and late phase development, our teams of expert scientists possess a wealth of experience in developing clinical candidates into optimal formulations and manufacturing high-quality oral dose products for all phases of clinical trials. Operating both non-GMP and GMP facilities we have complementary equipment trains and integrated technical teams to facilitate technology transfer providing a seamless transition between formulation and process development, and clinical trial material manufacturing. Through a range of flexible and fully tailored unit operations including blending, roller compaction, high shear granulation, encapsulation (including Xcelodose) micro encapsulation and fluid bed processing, we offer the following oral dose formulations with batch sizes ranging from grams to tons: • API / powder in hard gelatin capsules or bottles, including micro-dosing • Formulated blends in hard gelatin capsules or bottles • Tablets (coated) • Mini-tablets • Granules • Beads/pellets • Non-sterile liquid in capsules or bottles • Immediate and modified release • Fixed dose combination products • Potent and highly potent products (OEL as low as 0.05 ug/m3/8 hours) • Specialist paediatric drug development expertise Analytical Solutions: We employ over 700 highly skilled analysts working in state-of-the-art, fully certified GMP laboratories across Europe and the US with significant experience in the analysis of both small and large molecules. We support drug substance (API) and drug product (finished product) analytics across all phases of clinical development through to commercial release. We offer a range of tailored services including: • Method development • Method validation • Method transfer • Stability programmes • Release analysis: all lifecycle stages • Spectroscopy services • Investigational analysis • Reference standard management • Microbiological testing • Physical sciences • Bio-pharmaceutical testing • Analytical support for clinical trial supplies Commercial Manufacture Solutions: Scaling up from our oral dose development assets and expertise through registration and launch into commercial supply, or transferring existing commercial products, we support your commercial manufacturing needs with flexibility and expertise. With blend sizes from 10kgs up to 2.5 tons, our range of state-of-the-art processing equipment is designed to enable scalability to the batch size requirements of your product for a range of presentations including: • Tablets • Mini-tablets • Capsules • Powders • Granules • Beads/pellets • Non-sterile liquids • Potent and highly potent products (OEL as low as 0.05 ug/m3/8 hours) • Specialist paediatric drug manufacturing expertise Commercial Packaging Solutions: Our high and low throughput operations provide the flexibility and efficiency necessary to meet your ongoing and fluctuating demand. Our commercial facilities in Europe and the US, combined with our local expertise offers flexible, quality-led commercial pharmaceutical packaging solutions tailored to meet your specific needs. Our range of primary packaging solutions include: • Tablets • Mini-tablets • Capsules • Powders • Granules • Non-sterile liquid • Our secondary packaging, labelling and assembly capabilities include: • Bottles Vials / ampoules • Pre-filled syringes • Wallets / blister cards • Auto-injectors • Cartons • Sachets • Stick packs • Offline blister printing Innovative, specialist packaging solutions including: • Specialist paediatric drug packaging expertise • Expert cell and gene therapy (ATMP) Ultra Low Temperature (ULT) solutions (-20° to -80°) • Complex medical kit assembly solutions via our unique, custom built semi-automated packaging technology Support Solutions: We provide a wide range of tailored support and consultancy services to help guide you through every aspect of your unique development and commercialisation journey. Find out more – www.almacgroup.com
Alida Biosciences
At Alida Biosciences, we develop cutting‑edge tools for RNA modification‑based discovery, diagnostics, therapeutics, and biotechnological applications. Our mission is to empower the evaluation of RNA code beyond primary sequence. Built on deep expertise in protein engineering and enzymology, our innovative technologies position us as leaders in epitranscriptomic tools development. Our products enable highly sensitive RNA modification detection and quantification through a simple workflow and integrated bioinformatics pipeline—empowering confident exploration of complex biological mechanisms from early research to clinical breakthroughs.
Alamar Biosciences
Alamar Biosciences is powering precision proteomics with automated, high throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels. Our innovative ARGO™ HT System allows for a fully automated workflow with
Agilent Technologies
As a global leader in analytical and clinical laboratory technologies, Agilent is committed to helping our scientists bring great science to life. Leveraging more than 50 years of analytical and clinical laboratory expertise, we deliver trusted answers to our customers’ most critical questions and challenges. We passionately help scientists and clinicians make the smallest everyday advancements and life-changing discoveries that advance the quality of life. | Agilent is a global leader in analytical and clinical laboratory technologies, delivering innovative instruments, consumables, services, and expertise that help customers bring great science to life. Serving the life sciences, diagnostics, and applied chemical markets, Agilent supports laboratories worldwide with a comprehensive portfolio spanning genomics applications such as sample quality control (QC), next-generation sequencing (NGS), microarrays, CRISPR, PCR/qPCR, bioreagents, and advanced data analysis tools for interpretation and reporting. Our trusted technologies and commitment to scientific collaboration empower researchers to confidently generate and apply genetic insights that drive discovery, innovation, and informed decision-making. From sample preparation to data analysis, Agilent delivers efficient, accurate, and cost-effective solutions tailored to the evolving needs of modern laboratories across diverse research and clinical domains. | Agilent Technologies leads the industry with robust, reliable instruments that provide the ability to analyze, confirm and quantify substances of interest. Our workflow solutions enable you to maintain stringent practices from sample preparation, through analysis, to final report. When combined with our informatics architecture, large quantities of data can be managed while preserving the integrity and security of the results. Agilent offers a complete line of GC, LC, MS and Spectroscopy instruments and technologies, as well as the related consumables, support and services. For more information visit our website – www.agilent.com. | As a global leader in laboratory technologies, Agilent supports the lithium-ion battery industry with advanced analytical instruments, vacuum and leak detection equipment, and comprehensive laboratory supplies. Our reliable chromatography, mass spectrometry, and spectroscopy instruments meet critical testing needs across the battery supply chain. We ensure high standards of quality and efficiency with tailored solutions and provide essential spares, consumables, and certified reference materials. By offering analytical method development and application consulting, we help optimize testing economics and support the entire battery workflow, driving advancements and sustainability in the industry. | Agilent Technologies leads the industry with robust, reliable instruments that provide the ability to analyze, confirm and quantify substances of interest. Whether you are in raw material testing, including recycling, or scientific research work, Agilent supports companies with their transition to renewable energy. Agilent offers a complete line of analytical equipment and supplies, as well as training, method development and technical consulting. Whether you are a startup needing finance and method development support, or a large battery manufacturer needing 24/7 uptime on instruments to meet production targets, Agilent is your partner for success. For more information visit our website – www.agilent.com.